CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00106756
NCT00106756N/ACompleted

Familial Exudative Vitreoretinopathy Clinical and Molecular Studies

National Eye Institute (NEI)·observational·Posted Mar 30, 2005·Updated Jul 2, 2017

In Brief

An observational study for Exudatiaon and 5 related conditions. Completed, across 2 sites in 2 countries.

Detailed Summary

This study will examine the extent of the vision problem in familial exudative vitreoretinopathy (FEVR) and try to identify the genes responsible for this hereditary eye disorder. Patients with FEVR have incomplete formation of blood vessels in the periphery of the retina (the inner part of the eye that is responsible for vision). As a result, abnormal vessels can form and retinal detachment and vitreous bleeding can occur, causing significant vision loss. Vision loss usually begins in childhood, gradually worsening over time. Some patients eventually become blind. Patients of all ages with FEVR and their family members may be eligible for this study. Participants undergo the following tests and procedures: * Family history, especially regarding eye disease. A family tree is drawn. * Blood draw for genetic testing related to FEVR. * Eye examination to assess visual acuity (eye chart test) and eye pressure, and to examine pupils, lens, retina and eye movements. The pupils are dilated with drops for this examination. * Fluorescein angiography to evaluate the eye's blood vessels. A yellow dye is injected into an arm vein and travels to the blood vessels in the eyes. Pictures of the retina are taken using a camera that flashes a blue light into the eye. The pictures show if any dye has leaked from the vessels into the retina, indicating possible blood vessel abnormality. * Patients affected with FEVR will also undergo DEXA scan to look for osteoporosis. X-rays are used to scan the hip, forearm and spine for bone density measurements.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesCanada, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 30, 2005
Enrollment StartMar 18, 2005
Primary CompletionNov 1, 2006
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 21.3 years ago